| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51dd24b692ace975be34b3f6d3719823 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22 |
| filingDate |
2002-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f2102785e3df412029c7feb74db80ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_832435ec7a8f002f4970a7a4992a5a8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d59892815c72eedb8e13be12c5dabe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6d7e8b1866f3b1e0b5fece4cf15fd7 |
| publicationDate |
2004-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1449541-A1 |
| titleOfInvention |
Compositions inhibiting rejection in organ transplantation and method of using the same |
| abstract |
A novel and effective strategy for organntransplantation is provided. A therapeutic agent and methodnfor preventing an acute rejection in a transplanted organnand improving prognosis are provided. A therapeutic agentnfor suppressing a rejection in organ transplantation, whichncomprises an NF-κB decoy compound, is provided.nRepresentatively, the organ transplantation is kidneyntransplantation. The therapeutic agent further comprisesnan ultrasonic inspection contrast agent. A therapeuticnagent for improving prognosis in organ transplantation isnalso provided. The therapeutic agent is administered intona donor organ. The transfection efficiency of the NF-κB decoyncompound into the organ may be enhanced by ultrasoundntreatment. |
| priorityDate |
2001-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |